TBPH20260821C20
TBPH Aug 21 2026 20.00 Call (TBPH260821C00020000)
option OPRA

theravance biopharma is a biopharmaceutical company with one approved product, vibativ® (telavancin), that was discovered and developed internally, a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies.